DempoChem Logo
  1. HomeHome
  2. /ProductsProducts
  3. /Building BlocksBuilding Blocks
  4. /Heterocyclic ScaffoldsHeterocyclic Scaffolds
  5. /Aromatic HeterocyclesAromatic Heterocycles
  6. /Tazemetostat HydrobromideTazemetostat Hydrobromide
Chemical structure of CAS 1467052-75-0

Tazemetostat Hydrobromide

In Stock•Starting at $135 for 100 mg•Purity ≥ 98%
CAS No.1467052-75-0
MDL No.MFCD32201156
MFC34H45BrN4O4
MW653.60
InChI KeyUQRICAQPWZSJNF-UHFFFAOYSA-N
CUSTOM SYNTHESISPRECLINICAL SUPPORT→

Pricing & Availability

Pack SizePurityPriceAvailabilityAction
100 mg98%$135In Stock
250 mg98%$228In Stock
1 g98%$610In Stock
5 g98%$2221In Stock
Custom synthesis and bulk supply options are available upon request.

Product Information

CAS No.1467052-75-0
Product NameTazemetostat Hydrobromide

Biological Targets

EZH2

Associated Conditions

sarcoma·prostate cancer·neoplasm·small cell lung carcinoma·follicular lymphoma
* The information provided here is compiled from public sources and is for reference only.

Related Articles

Studies related to this compound and its mechanism of action

Hyperoxia and red cell 2,3-diphosphoglycerate.

Toxicology and applied pharmacology • Vol. 36, Issue 1 • 1976
PMID: 5789DOI: 10.1016/0041-008x(76)90025-9

Documentation

Similar Products

  • Tazemetostat

    CAS No.1403254-99-8

Your Partner for
Complex Chemistry
logo
  • About Us
  • Perspectives
  • Products
  • Contact
  • Preclinical Development
  • Technologies
  • Custom Synthesis
Ready to start your project?

Provide your target molecule or project specifications to align on a tailored development and scale-up pathway with our scientific team.

START A PROJECT
Westerstraat 10, 3016 DH, Rotterdam, The Netherlands
Westerstraat 10, 3016 DH, Rotterdam, The Netherlands
logo

All products are supplied strictly for research and development use only and are not intended for human or veterinary administration, diagnostic use, or therapeutic use. Preclinical and related services are provided solely for research and development purposes and do not constitute clinical diagnosis, treatment, or veterinary care.

©2026 DempoChem. All Rights Reserved.
DHLFedExUPSPostNL
CLIENT PORTAL|TERMS AND CONDITIONS|PRIVACY POLICY|
  • Products
    • CDMO Compounds
    • API & Candidates
  • Services
    CDMO & Manufacturing
    • Custom Synthesis
    • Process Development
    • Lab To Pilot
    • Commercialization
    • Generic APIs
    CRO
    • Preclinical
    • Pharmacology & Efficacy
    • DMPK & Bioanalysis
    • Toxicology & Safety
    • Disease Models
    Technologies
    • High-Potent
    • Chiral Synthesis
    • Cloud Synthesis
    • Fermentation
    • Flow Chemistry
    • Biocatalysis
    Support
    • Regulatory Support
    • Supply Chain Solutions
  • About
  • Perspectives
  • Contact